Article Details
Retrieved on: 2019-03-30 20:09:05
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Meditor Group Ltd increased its stake in Esperion Therapeutics Inc (ESPR) by 1.9% based on its latest 2018Q4 regulatory filing with the SEC. Meditor ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here